Cannabis Bioscience International Holdings annual revenue
2023
2024
2025
Cannabis Bioscience International Holdings Revenue Growth & History (CBIH)
Cannabis Bioscience International Holdings reported $303,022 in revenue for fiscal 2025, an increase of 21.77% from the previous fiscal year.
View full Cannabis Bioscience International Holdings company overviewCannabis Bioscience International Holdings annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-05-31 | $303,022 | $54,181 | +21.77% |
| 2024 | 2024-05-31 | $248,841 | −$67,984 | −21.46% |
| 2023 | 2023-05-31 | $316,825 | — | — |
Cannabis Bioscience International Holdings quarterly revenue
Q1.12
Q2.12
Q3.12
Q1.12
Q2.12
Q3.12
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q3 2026 | 2026-02-28 | $11,205 | −$3,726 | −24.95% |
| Q2 2026 | 2025-11-30 | $53,266 | −$20,982 | −28.26% |
| Q1 2026 | 2025-08-31 | $24,200 | −$154,687 | −86.47% |
| Q4 2025 | 2025-05-31 | $34,956 | −$40,905 | −53.92% |
| Q3 2025 | 2025-02-28 | $14,931 | −$21,480 | −58.99% |
| Q2 2025 | 2024-11-30 | $74,248 | $10,500 | +16.47% |
| Q1 2025 | 2024-08-31 | $178,887 | $106,066 | +145.65% |
| Q4 2024 | 2024-05-31 | $75,861 | — | — |
| Q3 2024 | 2024-02-29 | $36,411 | −$14,841 | −28.96% |
| Q2 2024 | 2023-11-30 | $63,748 | −$18,833 | −22.81% |
| Q1 2024 | 2023-08-31 | $72,821 | — | — |
| Q3 2023 | 2023-02-28 | $51,252 | — | — |
| Q2 2023 | 2022-11-30 | $82,581 | — | — |
| Q3 2012 · Feb 29 | 2012-02-29 | $8.6M | −$12.2M | −58.75% |
| Q2 2012 · Nov 30 | 2011-11-30 | $15.5M | −$10.4M | −40.16% |
| Q1 2012 · Aug 31 | 2011-08-31 | $17.3M | −$3.9M | −18.38% |
| Q3 2012 · Feb 28 | 2011-02-28 | $20.8M | — | — |
| Q2 2012 · Nov 30 | 2010-11-30 | $25.9M | — | — |
| Q1 2012 · Aug 31 | 2010-08-31 | $21.2M | — | — |
Cannabis Bioscience International Holdings revenue growth trends
Cannabis Bioscience International Holdings's latest reported quarter, Q3 2026, generated $11,205 in revenue, a decrease of 24.95% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Cannabis Bioscience International Holdings source filings ↗